Resultado de búsqueda
Through his research, Professor Shehabi is considered a national and an international authority on sedation and delirium management and on the use of dexmedetomidine in critical care and perioperative medicine.
Yahya SHEHABI, Professor and Program Medical Director | Cited by 11,692 | | Read 312 publications | Contact Yahya SHEHABI
Prof Yahya Shehabi leads the research team and activities within the Department of Surgery, School of Clinical Sciences at Monash Health, Monash University. He is dual qualified in Anaesthesia and Intensive Care, holds a PhD from the University of New South Wales and an Executive Master of Business Administration from the University of ...
Abstract. Purpose: To quantify potential heterogeneity of treatment effect (HTE), of early sedation with dexmedetomidine (DEX) compared with usual care, and identify patients who have a high probability of lower or higher 90-day mortality according to age, and other identified clusters.
27 de jun. de 2019 · Abstract. Background: Dexmedetomidine produces sedation while maintaining a degree of arousability and may reduce the duration of mechanical ventilation and delirium among patients in the intensive care unit (ICU).
Dr Shehabi is the Chief Investigator of the Sedation Practice in Intensive Care Evaluation (SPICE) research program, a multicenter multinational program endorsed by the...
Yahya SHEHABI, Professor and Program Medical Director | Cited by 11,037 | | Read 309 publications | Contact Yahya SHEHABI
